Termination TerugBetaalRegeling Fampyra®
Fampyra® is fully reimbursement from the 1st of September 2019. For this reason the co-payment for Fampyra ended per August 31,...
Launch of TerugBetaalRegeling Veltassa®
The health insurer does not fully reimburse Veltassa® 8.4g. The producer of this medicine has therefore asked TBR Nederland to...
Amendment to TerugBetaalRegeling Forxiga® and Xigduo®
The health insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of...
Launch of TerugBetaalRegeling Lokelma®
The health insurer does not fully reimburse Lokelma® 5g and 10g. The producer of this medicine has therefore asked TBR Nederland...
Relaunch of TerugBetaalRegeling Plenadren®
The health insurer does not fully reimburse Plenadren® 5mg and 20mg. The producer of this medicine has therefore asked TBR...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine